Global Pharma Regulations, Ethics in Pharma Li-Anne Rowswell Mufson Global Pharma Regulations, Ethics in Pharma Li-Anne Rowswell Mufson

European Union Pharmaceutical Industry Package

In December 2025, negotiators reached a historic political agreement on a major overhaul of drug laws known as the EU pharma package. As these massive new rules roll out across Europe, pharmaceutical companies face a complicated double reality. They must adapt to a unified European market while simultaneously managing messy, localized differences from country-specific ethics boards and regional testing requirements.

Read More
FDA Regulations Li-Anne Rowswell Mufson FDA Regulations Li-Anne Rowswell Mufson

ICH Q12: Post-Approval Change Management for Pharmaceutical Product Lifecycle Management

The formalized roll-out of ICH Q12 mechanisms introduces an organized approach to identifying and managing regulatory commitments. This framework allows manufacturers to execute routine modifications under the oversight of their internal Pharmaceutical Quality System (PQS), reducing the burden of prior-approval regulatory filings.

Read More